Provided by Tiger Trade Technology Pte. Ltd.

Alkermes PLC

29.52
+0.22000.75%
Post-market: 29.520.00000.00%17:01 EST
Volume:1.81M
Turnover:52.93M
Market Cap:4.87B
PE:14.63
High:29.59
Open:29.16
Low:28.97
Close:29.30
52wk High:36.45
52wk Low:25.17
Shares:165.12M
Float Shares:162.42M
Volume Ratio:1.23
T/O Rate:1.11%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.02
EPS(LYR):2.22
ROE:22.35%
ROA:9.99%
PB:2.81
PE(LYR):13.30

Loading ...

Alkermes EVP R&D and Chief Medical Officer Craig C. Hopkinson Reports Disposal of Common Shares

Reuters
·
Dec 06

Alkermes EVP R&D and Chief Medical Officer Craig C. Hopkinson Reports Disposal of Common Shares

Reuters
·
Dec 02

Avadel Pharmaceuticals Plc - Scheme Meeting and Egm Scheduled for January 12, 2026

THOMSON REUTERS
·
Dec 02

A Look at Alkermes (ALKS) Valuation Following Q3 Earnings Beat and Raised 2025 Outlook

Simply Wall St.
·
Dec 01

BUZZ-H Lundbeck steps down from takeover for Avadel, shares rise 3%

Reuters
·
Nov 27

Alkermes plc to Participate in Upcoming Investor Conferences

Reuters
·
Nov 26

Alkermes (ALKS): Evaluating Valuation After Promising Vibrance-2 Narcolepsy Drug Results

Simply Wall St.
·
Nov 20

Deals of the day-Mergers and acquisitions

Reuters
·
Nov 20

BRIEF-H Lundbeck A/S Says Noted That Our Offer For Acquiring Avadel No Longer Is Considered Superior By Their Board, We Are Currently Considering Our Options

Reuters
·
Nov 19

H Lundbeck a/S: Noted That Our Offer for Acquiring Avadel No Longer Is Considered Superior by Their Board, We Are Currently Considering Our Options

THOMSON REUTERS
·
Nov 19

Alkermes Raises Offer to Acquire Avadel Pharmaceuticals

Reuters
·
Nov 19

Alkermes: Proposed Deal Consideration Consists of $21.00 in Cash and One Non-Transferable CVR for Potential Additional Cash Payment of $1.50/Share

THOMSON REUTERS
·
Nov 19

Alkermes Plc - Deal Valued up to $22.50 per Share

THOMSON REUTERS
·
Nov 19

Alkermes Plc Announces Increased Offer to Acquire Avadel Pharmaceuticals Plc

THOMSON REUTERS
·
Nov 19

Alkermes Plc - Avadel Board Rejects Lundbeck Proposal as Superior

THOMSON REUTERS
·
Nov 19

Alkermes Plc: Avadel Board Determined Terms of CVR in Alkermes' Increased Offer Are Superior to Terms of CVR Included in Lundbeck Proposal

THOMSON REUTERS
·
Nov 19

Alkermes Plc - Revised Deal Approved by Alkermes and Avadel Boards

THOMSON REUTERS
·
Nov 19

Alkermes Is Maintained at Buy by Truist Securities

Dow Jones
·
Nov 17

Alkermes Plc : Truist Securities Raises Target Price to $55 From $50

THOMSON REUTERS
·
Nov 17

Truist Raises Price Target on Alkermes to $55 From $50, Keeps Buy Rating

MT Newswires Live
·
Nov 17